NCT02896400

Brief Summary

The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-methods approach will be used to identify the components that were efficacious within the proposed cost constraint, along with feasibility and acceptability to providers and subjects. The investigators will then assemble an intervention that maximizes efficacy, given a cost-effectiveness constraint and findings from a qualitative analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,056

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 12, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

February 13, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2019

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

November 16, 2020

Completed
Last Updated

December 4, 2020

Status Verified

November 1, 2020

Enrollment Period

2.5 years

First QC Date

September 6, 2016

Results QC Date

August 21, 2020

Last Update Submit

November 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tobacco Abstinence

    Abstinence self reported and verified by exhaled carbon monoxide

    3 months

Study Arms (16)

BNI+NRT+QL+Text

EXPERIMENTAL

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Behavioral: Brief Negotiated Interview (BNI)Drug: Nicotine replacement therapy (NRT)Other: CT Smokers Quitline (QL)Other: SmokefreeText (Text)

BNI+NRT+QL

EXPERIMENTAL

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)

Behavioral: Brief Negotiated Interview (BNI)Drug: Nicotine replacement therapy (NRT)Other: CT Smokers Quitline (QL)

BNI+NRT+Text

EXPERIMENTAL

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)

Behavioral: Brief Negotiated Interview (BNI)Drug: Nicotine replacement therapy (NRT)Other: SmokefreeText (Text)

BNI+NRT

EXPERIMENTAL

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply

Behavioral: Brief Negotiated Interview (BNI)Drug: Nicotine replacement therapy (NRT)

BNI+QL+Text

EXPERIMENTAL

Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Behavioral: Brief Negotiated Interview (BNI)Other: CT Smokers Quitline (QL)Other: SmokefreeText (Text)

BNI+QL

EXPERIMENTAL

Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL)

Behavioral: Brief Negotiated Interview (BNI)Other: CT Smokers Quitline (QL)

BNI+Text

EXPERIMENTAL

Brief Negotiated Interview (BNI) Registration in SmokefreeText (Text)

Behavioral: Brief Negotiated Interview (BNI)Other: SmokefreeText (Text)

BNI only

EXPERIMENTAL

Brief Negotiated Interview (BNI)

Behavioral: Brief Negotiated Interview (BNI)

NRT+QL+Text

EXPERIMENTAL

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Drug: Nicotine replacement therapy (NRT)Other: CT Smokers Quitline (QL)Other: SmokefreeText (Text)

NRT+QL

EXPERIMENTAL

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)

Drug: Nicotine replacement therapy (NRT)Other: CT Smokers Quitline (QL)

NRT+Text

EXPERIMENTAL

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)

Drug: Nicotine replacement therapy (NRT)Other: SmokefreeText (Text)

NRT only

EXPERIMENTAL

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply

Drug: Nicotine replacement therapy (NRT)

QL+Text

EXPERIMENTAL

Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Other: CT Smokers Quitline (QL)Other: SmokefreeText (Text)

QL only

EXPERIMENTAL

Referral to CT Smokers Quitline (QL)

Other: CT Smokers Quitline (QL)

Text only

EXPERIMENTAL

Registration in SmokefreeText (Text)

Other: SmokefreeText (Text)

Control

NO INTERVENTION

Control arm, no intervention

Interventions

Brief motivational interview on smoking behavior

BNI onlyBNI+NRTBNI+NRT+QLBNI+NRT+QL+TextBNI+NRT+TextBNI+QLBNI+QL+TextBNI+Text

6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece.

BNI+NRTBNI+NRT+QLBNI+NRT+QL+TextBNI+NRT+TextNRT onlyNRT+QLNRT+QL+TextNRT+Text

Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.

BNI+NRT+QLBNI+NRT+QL+TextBNI+QLBNI+QL+TextNRT+QLNRT+QL+TextQL onlyQL+Text

Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.

BNI+NRT+QL+TextBNI+NRT+TextBNI+QL+TextBNI+TextNRT+QL+TextNRT+TextQL+TextText only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • have smoked \>= 100 cigarettes lifetime
  • describe themselves as every or some day smokers
  • smoke at least 5 cigarettes/day
  • own a cellphone with texting capability
  • are able to give written informed consent

You may not qualify if:

  • Inability to read or understand English
  • currently receiving formal tobacco dependence treatment
  • life-threatening or unstable medical, surgical, or psychobehavioral condition
  • unable to provide at least one collateral contact
  • live out-of-state
  • leaving the ED against medical advice
  • pregnant (self-report or urine testing), nursing, or trying to conceive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale School of Medicine

New Haven, Connecticut, 06519, United States

Location

Related Publications (1)

  • Bernstein SL, Dziura J, Weiss J, Miller T, Vickerman KA, Grau LE, Pantalon MV, Abroms L, Collins LM, Toll B. Tobacco dependence treatment in the emergency department: A randomized trial using the Multiphase Optimization Strategy. Contemp Clin Trials. 2018 Mar;66:1-8. doi: 10.1016/j.cct.2017.12.016. Epub 2017 Dec 27.

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

Nicotine Replacement Therapy

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Results Point of Contact

Title
Steven L. Bernstein, MD
Organization
Yale School of Medicine

Study Officials

  • Steven L Bernstein, MD

    Yale School of Medicine, Department of Emergency Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2016

First Posted

September 12, 2016

Study Start

February 13, 2017

Primary Completion

August 14, 2019

Study Completion

August 14, 2019

Last Updated

December 4, 2020

Results First Posted

November 16, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations